Digestive Enzyme Supplements Market Size, Share & Trends Analysis Report By Origin, By Application (Additional Supplements, Medical & Infant Nutrition, Sports Nutrition), By Nature, By Region, And Segment Forecasts, 2025 - 2030

January 2025 | 100 pages | ID: D606CB104AC9EN
Grand View Research, Inc.

US$ 3,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 4 Business Days

Digestive Enzyme Supplements Market Growth & Trends

The global digestive enzyme supplements market size is expected t%li%reach USD 2.12 billion by 2030, expanding at a CAGR of 6.2% from 2025 t%li%2030, according t%li%a new report published by Grand View Research, Inc. Growing consumer awareness regarding the severity of digestive disorders coupled with the need for good health is expected t%li%stimulate industry growth over the forecast period. The increasing incidence of gastrointestinal tract diseases, such as irritable bowel syndrome, constipation, inflammatory bowel disease, and gastroesophageal reflux disease, has raised concerns towards stomach health, which in turn is anticipated t%li%fuel product growth.

Digestive enzyme supplements have t%li%comply with various regulatory bodies including the U.S. Food and Drug Administration, Dietary Supplement Health and Education Act of 1994, and Natural Health Products Regulations for manufacturing and use. Increasing number of gymnasiums and fitness centers in emerging markets including China and India on account of rising awareness towards muscle improvement and reducing fat content among individuals will propel product demand.

Digestive Enzyme Supplements Market Report Highlights
    • The animal-based digestive enzyme supplements segment will dominate the global industry in 2024. Unhealthy lifestyles, awareness regarding gut health and overall well-being, and increasing healthcare spending are adding t%li%the growth of this segment.
    • The additional supplements segment dominated the global digestive enzyme supplements industry in 2024. This is attributed t%li%factors such as changing lifestyles, growing health consciousness among consumers, increasing demand from urban consumers, and more.
  • The conventional nature segment held a significant revenue share of the global digestive enzyme supplements industry in 2024. Users prefer conventional products characterized by animal-based enzymes and tested formulations during treatment.
  • North America dominated the global digestive enzyme supplements industry in 2024. This market is primarily driven by increasing demand from health-conscious urban consumers, growing utilization in the medical treatment associated with dietary ailments, and rising use in sports nutrition.
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
  1.3.1. Purchased Database
  1.3.2. GVR’s Internal Database
  1.3.3. Secondary Sources & Third-Party Perspectives
  1.3.4. Primary Research
1.4. Information Analysis
  1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

CHAPTER 3. DIGESTIVE ENZYME SUPPLEMENTS MARKET VARIABLES, TRENDS & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent Market Outlook
  3.1.2. Related Market Outlook
3.2. Industry Value Chain Analysis
  3.2.1. Profit Margin Analysis (Industry-level)
3.3. Market Dynamics
  3.3.1. Market Driver Analysis
  3.3.2. Market Restraint Analysis
  3.3.3. Market Opportunities
  3.3.4. Market Challenges
3.4. Industry Analysis Tools
  3.4.1. Porter’s Five Forces Analysis
3.5. Market Entry Strategies

CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS

4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Ingredient Adoption
4.5. Observations & Recommendations

CHAPTER 5. DIGESTIVE ENZYME SUPPLEMENTS MARKET: ORIGIN ESTIMATES & TREND ANALYSIS

5.1. Digestive Enzyme Supplements Market, By Origin: Key Takeaways
5.2. Origin Movement Analysis & Market Share, 2024 & 2030
5.3. Market Estimates & Forecasts, By Origin, 2018 - 2030 (USD Billion)
  5.3.1. Animal
    5.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  5.3.2. Plant
    5.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  5.3.3. Microbial
    5.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  5.3.4. Others
    5.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)

CHAPTER 6. DIGESTIVE ENZYME SUPPLEMENTS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

6.1. Digestive Enzyme Supplements Market, By Application: Key Takeaways
6.2. Application Movement Analysis & Market Share, 2024 & 2030
6.3. Market Estimates & Forecasts, by Application, 2018 - 2030 (USD Billion)
  6.3.1. Additional Supplements
    6.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  6.3.2. Medical & Infant Nutrition
    6.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  6.3.3. Sports Nutrition
    6.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)

CHAPTER 7. DIGESTIVE ENZYME SUPPLEMENTS MARKET: NATURE ESTIMATES & TREND ANALYSIS

7.1. Digestive Enzyme Supplements Market, By Nature: Key Takeaways
7.2. Nature Movement Analysis & Market Share, 2024 & 2030
7.3. Market Estimates & Forecasts, by Nature, 2018 - 2030 (USD Billion)
  7.3.1. Conventional
    7.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  7.3.2. Organic
    7.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)

CHAPTER 8. DIGESTIVE ENZYME SUPPLEMENTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS

8.1. Digestive Enzyme Supplements Market: Regional Outlook
8.2. Regional Marketplaces: Key Takeaways
8.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Billion)
  8.3.1. North America
    8.3.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.1.2. U.S.
      8.3.1.2.1. Key Country Dynamics
      8.3.1.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.1.3. Canada
      8.3.1.3.1. Key Country Dynamics
      8.3.1.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.1.4. Mexico
      8.3.1.4.1. Key Country Dynamics
      8.3.1.4.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  8.3.2. Europe
    8.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.2.2. Germany
      8.3.2.2.1. Key Country Dynamics
      8.3.2.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.2.3. U.K.
      8.3.2.3.1. Key Country Dynamics
      8.3.2.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.2.4. France
      8.3.2.4.1. Key Country Dynamics
      8.3.2.4.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.2.5. Italy
      8.3.2.5.1. Key Country Dynamics
      8.3.2.5.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.2.6. Spain
      8.3.2.6.1. Key Country Dynamics
      8.3.2.6.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  8.3.3. Asia Pacific
    8.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.3.2. China
      8.3.3.2.1. Key Country Dynamics
      8.3.3.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.3.3. India
      8.3.3.3.1. Key Country Dynamics
      8.3.3.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.3.4. Japan
      8.3.3.4.1. Key Country Dynamics
      8.3.3.4.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.3.5. Australia
      8.3.3.5.1. Key Country Dynamics
      8.3.3.5.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  8.3.4. Latin America
    8.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.4.2. Brazil
      8.3.4.2.1. Key Country Dynamics
      8.3.4.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.4.3. Argentina
      8.3.4.3.1. Key Country Dynamics
      8.3.4.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
  8.3.5. Middle East
    8.3.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.5.2. South Africa
      8.3.5.2.1. Key Country Dynamics
      8.3.5.2.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    8.3.5.3. Saudi Arabia
      8.3.5.3.1. Key Country Dynamics
      8.3.5.3.2. Market Estimates and Forecast, 2018 - 2030 (USD Billion)

CHAPTER 9. DIGESTIVE ENZYME SUPPLEMENTS MARKET: COMPETITIVE ANALYSIS

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company Categorization
9.3. Participant’s Overview
9.4. Financial Performance
9.5. Ingredient Benchmarking
9.6. Company Heat Map Analysis
9.7. Strategy Mapping
9.8. Company Profiles
  9.8.1. Enzymes, Inc.
    9.8.1.1. Company Overview
    9.8.1.2. Financial Performance
    9.8.1.3. Ingredient Portfolios
    9.8.1.4. Strategic Initiatives
  9.8.2. Amano Enzyme Inc.
    9.8.2.1. Company Overview
    9.8.2.2. Financial Performance
    9.8.2.3. Ingredient Portfolios
    9.8.2.4. Strategic Initiatives
  9.8.3. Enzymedica
    9.8.3.1. Company Overview
    9.8.3.2. Financial Performance
    9.8.3.3. Ingredient Portfolios
    9.8.3.4. Strategic Initiatives
  9.8.4. Klaire Laboratories
    9.8.4.1. Company Overview
    9.8.4.2. Financial Performance
    9.8.4.3. Ingredient Portfolios
    9.8.4.4. Strategic Initiatives
  9.8.5. National Enzyme Company
    9.8.5.1. Company Overview
    9.8.5.2. Financial Performance
    9.8.5.3. Ingredient Portfolios
    9.8.5.4. Strategic Initiatives
  9.8.6. Advanced Enzyme Technologies
    9.8.6.1. Company Overview
    9.8.6.2. Financial Performance
    9.8.6.3. Ingredient Portfolios
    9.8.6.4. Strategic Initiatives
  9.8.7. Metagenics
    9.8.7.1. Company Overview
    9.8.7.2. Financial Performance
    9.8.7.3. Ingredient Portfolios
    9.8.7.4. Strategic Initiatives
  9.8.8. Danone
    9.8.8.1. Company Overview
    9.8.8.2. Financial Performance
    9.8.8.3. Ingredient Portfolios
    9.8.8.4. Strategic Initiatives
  9.8.9. Integrative Therapeutics
    9.8.9.1. Company Overview
    9.8.9.2. Financial Performance
    9.8.9.3. Ingredient Portfolios
    9.8.9.4. Strategic Initiatives
  9.8.10. Vox Nutrition
    9.8.10.1. Company Overview
    9.8.10.2. Financial Performance
    9.8.10.3. Ingredient Portfolios
    9.8.10.4. Strategic Initiatives
  9.8.11. Klaire Laboratories
    9.8.11.1. Company Overview
    9.8.11.2. Financial Performance
    9.8.11.3. Ingredient Portfolios
    9.8.11.4. Strategic Initiatives


More Publications